Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Allan Reine > Profile

Allan Reine

Affiliations

  • Chief Executive Officer at Prime Medicine Inc. (PRME), 2025-05-22
  • Chief Financial Officer at Foghorn Therapeutics Inc. (FHTX), 2024-01-17
  • Chief Financial Officer at Pieris Pharmaceuticals Inc. (PIRS), 2019-02-28
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PRME $1.18 125,000 $147,150.00 125,000 2025-05-21 Filing
PIRS $4.89 20,000 $97,800.00 65,000 2017-08-17 Filing
PIRS $4.79 45,000 $215,550.00 45,000 2017-08-16 Filing